AtlantiCare signed a letter of intent with John Brooks Recovery Center for AtlantiCare to acquire and become the parent company of JBRC, allowing it to enhance care for the growing population in need of substance use disorder and other behavioral health services, according to a Tuesday announcement from the Egg Harbor-based health care system.
Pending the signing of a definitive agreement and attaining regulatory approvals, AtlantiCare and JBRC expect to complete the transaction in early 2022.
JBRC provides clinically driven treatment options through two outpatient centers and one residential treatment facility.
“The continuum of care is extremely important at AtlantiCare and John Brooks Recovery Center — it guides our vision of building healthy communities together,” said Lori Herndon, CEO and president, AtlantiCare. “AtlantiCare and JBRC also share a long history of providing compassionate care and support to individuals struggling with substance use disorders, as well as their loved ones. AtlantiCare’s mission is to make a difference in health and healing, one person at a time, through caring and trusting relationships. By combining our complementary behavioral health capabilities, we would broaden and deepen our ability to reach individuals in need and provide the continuum of care and support that is so essential to their long-term recovery and brighter futures.”
AtlantiCare and JBRC have partnered before.
“The signing of this letter of intent is an exciting next step in the collaborative relationship JBRC and AtlantiCare have fostered,” said Michael Santillo, CEO, JBRC. “Our organizations are well versed in the unique assets, services and capabilities each brings to the table because we’ve been immersed in each other’s way of service for years. With this acquisition, we would strategize even more effective ways to leverage our resources to make lives better for individuals suffering from substance use disorders regardless of financial circumstances or socioeconomic background.”